Physician

Nehal Rashmikant Patel, M.D.

According to 2025 Medicare claims, Nehal Patel, M.D. (NPI: 1386762128) practices ophthalmology in the McAllen-Edinburg-Mission, TX market, with the plurality of this provider's patient population coming from Hidalgo, TX. This provider's primary affiliated billing organization is OPHTHALMIC CONSULTANTS OF TEXAS P.A. (NPI: 1063513794; TIN: 742879098) and primary practice location at 78503-1518.

Patel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 579 traditional Medicare patients, billed 18,601 HCPCS/CPT codes, and received $903,356 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 10,666 prescription claims across 1,721 beneficiaries totaling $1,207,181 in drug costs, led by Lumigan (Bimatoprost). 2017 DME data shows 26 claims. Open Payments data shows 21 records totaling $877. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $1,188,793 to $903,356. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $645,336 to $1,207,181. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,217	8,977	$1,188,793
2016	1,318	8,733	$1,202,382
2017	1,460	9,192	$1,306,844
2018	1,298	9,436	$1,322,792
2019	1,167	9,000	$1,281,096
2020	967	7,685	$1,070,510
2021	874	7,595	$1,035,824
2022	677	5,482	$779,540
2023	571	7,118	$733,218
2024	579	18,601	$903,356

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,269	7,224	$645,336
2016	1,446	8,531	$801,594
2017	1,746	10,607	$1,094,156
2018	1,670	10,876	$1,178,425
2019	1,658	10,517	$1,203,678
2020	1,719	11,862	$1,431,256
2021	1,674	11,047	$1,512,649
2022	1,524	9,834	$1,640,594
2023	1,566	10,030	$1,520,565
2024	1,721	10,666	$1,207,181

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	36	36	$1,770
2016	N/R	N/R	N/R
2017	26	26	$1,399
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
92014	Established patient complete exam of visual system	271	353	$85
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	272	416	$80
92083	Exam of visual field with extended testing	166	189	$40
92134	Imaging of retina	273	639	$30
92133	Imaging of optic nerve	175	188	$24

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lumigan	Bimatoprost	439	23,937	$224,218
Rhopressa	Netarsudil Mesylate	261	12,128	$119,347
Combigan	Brimonidine Tartrate/Timolol	299	15,914	$114,777
Restasis	Cyclosporine	82	4,476	$87,813
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	305	15,242	$49,818

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	21	$877	Genentech USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Nehal Rashmikant Patel, M.D.?

Tedicare shows public-source Medicare data for Nehal Rashmikant Patel, M.D. (NPI 1386762128), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nehal Rashmikant Patel, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Nehal Rashmikant Patel, M.D.?

Nehal Rashmikant Patel, M.D. is linked to OPHTHALMIC CONSULTANTS OF TEXAS P.A. (billing NPI 1063513794) in the available physician profile data.

Does Nehal Rashmikant Patel, M.D. have Open Payments data?

Nehal Rashmikant Patel, M.D. has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.